# Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes

> **NCT03258853** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 22 (actual)

## Conditions studied

- Cystic Fibrosis-related Diabetes

## Interventions

- **DEVICE:** Bionic Pancreas
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT03258853
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-26
- **Primary completion:** 2022-06-29
- **Final completion:** 2022-06-29
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03258853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03258853, "Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03258853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*